vs

Side-by-side financial comparison of ASPEN AEROGELS INC (ASPN) and Evolus, Inc. (EOLS). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($73.1M vs $41.3M, roughly 1.8× ASPEN AEROGELS INC). Evolus, Inc. runs the higher net margin — -14.6% vs -176.4%, a 161.8% gap on every dollar of revenue. On growth, Evolus, Inc. posted the faster year-over-year revenue change (6.7% vs -66.4%). Over the past eight quarters, Evolus, Inc.'s revenue compounded faster (4.6% CAGR vs -33.9%).

Aspen Aerogels Inc is a leading manufacturer of high-performance aerogel-based insulation and thermal management materials. It serves core sectors including renewable energy, oil and gas infrastructure, aerospace, commercial construction and industrial manufacturing, with key markets across North America, Europe and Asia-Pacific. Its products are prized for superior thermal resistance, fire safety and lightweight performance for harsh operating conditions.

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

ASPN vs EOLS — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.8× larger
EOLS
$73.1M
$41.3M
ASPN
Growing faster (revenue YoY)
EOLS
EOLS
+73.2% gap
EOLS
6.7%
-66.4%
ASPN
Higher net margin
EOLS
EOLS
161.8% more per $
EOLS
-14.6%
-176.4%
ASPN
Faster 2-yr revenue CAGR
EOLS
EOLS
Annualised
EOLS
4.6%
-33.9%
ASPN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ASPN
ASPN
EOLS
EOLS
Revenue
$41.3M
$73.1M
Net Profit
$-72.9M
$-10.7M
Gross Margin
-55.5%
66.9%
Operating Margin
-170.3%
23.8%
Net Margin
-176.4%
-14.6%
Revenue YoY
-66.4%
6.7%
Net Profit YoY
-741.7%
EPS (diluted)
$-0.87
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASPN
ASPN
EOLS
EOLS
Q1 26
$73.1M
Q4 25
$41.3M
$90.3M
Q3 25
$73.0M
$69.0M
Q2 25
$78.0M
$69.4M
Q1 25
$78.7M
$68.5M
Q4 24
$123.1M
$78.9M
Q3 24
$117.3M
$61.1M
Q2 24
$117.8M
$66.9M
Net Profit
ASPN
ASPN
EOLS
EOLS
Q1 26
$-10.7M
Q4 25
$-72.9M
$130.0K
Q3 25
$-6.3M
$-15.7M
Q2 25
$-9.1M
$-17.1M
Q1 25
$-301.2M
$-18.9M
Q4 24
$11.4M
$-6.8M
Q3 24
$-13.0M
$-19.2M
Q2 24
$16.8M
$-11.3M
Gross Margin
ASPN
ASPN
EOLS
EOLS
Q1 26
66.9%
Q4 25
-55.5%
65.7%
Q3 25
28.5%
66.5%
Q2 25
32.4%
65.3%
Q1 25
29.0%
68.1%
Q4 24
38.3%
66.7%
Q3 24
41.8%
68.9%
Q2 24
43.8%
70.3%
Operating Margin
ASPN
ASPN
EOLS
EOLS
Q1 26
23.8%
Q4 25
-170.3%
4.7%
Q3 25
-4.6%
-16.7%
Q2 25
-6.6%
-14.7%
Q1 25
-380.2%
-22.1%
Q4 24
12.0%
-2.9%
Q3 24
14.8%
-25.3%
Q2 24
17.0%
-11.5%
Net Margin
ASPN
ASPN
EOLS
EOLS
Q1 26
-14.6%
Q4 25
-176.4%
0.1%
Q3 25
-8.7%
-22.8%
Q2 25
-11.6%
-24.7%
Q1 25
-382.7%
-27.6%
Q4 24
9.2%
-8.6%
Q3 24
-11.1%
-31.4%
Q2 24
14.3%
-17.0%
EPS (diluted)
ASPN
ASPN
EOLS
EOLS
Q1 26
$-0.16
Q4 25
$-0.87
$0.01
Q3 25
$-0.08
$-0.24
Q2 25
$-0.11
$-0.27
Q1 25
$-3.67
$-0.30
Q4 24
$0.15
$-0.11
Q3 24
$-0.17
$-0.30
Q2 24
$0.21
$-0.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASPN
ASPN
EOLS
EOLS
Cash + ST InvestmentsLiquidity on hand
$156.9M
$49.8M
Total DebtLower is stronger
$65.5M
$156.4M
Stockholders' EquityBook value
$235.5M
Total Assets
$406.7M
$220.6M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASPN
ASPN
EOLS
EOLS
Q1 26
$49.8M
Q4 25
$156.9M
$53.8M
Q3 25
$150.7M
$43.5M
Q2 25
$167.6M
$61.7M
Q1 25
$192.0M
$67.9M
Q4 24
$220.9M
$87.0M
Q3 24
$113.5M
$85.0M
Q2 24
$91.4M
$93.7M
Total Debt
ASPN
ASPN
EOLS
EOLS
Q1 26
$156.4M
Q4 25
$65.5M
$146.1M
Q3 25
$70.1M
Q2 25
$77.3M
Q1 25
$95.4M
$121.8M
Q4 24
$95.0M
$121.5M
Q3 24
$93.7M
$121.2M
Q2 24
$120.9M
Stockholders' Equity
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
$235.5M
$-23.1M
Q3 25
$305.7M
$-28.8M
Q2 25
$308.8M
$-18.7M
Q1 25
$314.8M
$-6.6M
Q4 24
$614.7M
$5.5M
Q3 24
$507.6M
$5.9M
Q2 24
$517.8M
$19.3M
Total Assets
ASPN
ASPN
EOLS
EOLS
Q1 26
$220.6M
Q4 25
$406.7M
$225.9M
Q3 25
$491.4M
$219.0M
Q2 25
$525.1M
$228.8M
Q1 25
$555.0M
$213.4M
Q4 24
$895.1M
$232.6M
Q3 24
$782.6M
$229.6M
Q2 24
$748.6M
$233.8M
Debt / Equity
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
0.28×
Q3 25
0.23×
Q2 25
0.25×
Q1 25
0.30×
Q4 24
0.15×
22.00×
Q3 24
0.18×
20.58×
Q2 24
6.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASPN
ASPN
EOLS
EOLS
Operating Cash FlowLast quarter
$16.1M
Free Cash FlowOCF − Capex
$13.7M
FCF MarginFCF / Revenue
33.1%
Capex IntensityCapex / Revenue
6.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-4.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
$16.1M
$12.8M
Q3 25
$15.0M
$-14.7M
Q2 25
$-3.9M
$-24.8M
Q1 25
$5.6M
$-15.6M
Q4 24
$35.7M
$4.8M
Q3 24
$20.8M
$-5.7M
Q2 24
$6.8M
$-6.5M
Free Cash Flow
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
$13.7M
$11.3M
Q3 25
$5.9M
$-15.6M
Q2 25
$-16.8M
$-25.5M
Q1 25
$-7.4M
$-16.0M
Q4 24
$20.9M
$4.4M
Q3 24
$-50.0K
$-6.0M
Q2 24
$-18.0M
$-6.9M
FCF Margin
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
33.1%
12.6%
Q3 25
8.1%
-22.7%
Q2 25
-21.6%
-36.7%
Q1 25
-9.4%
-23.3%
Q4 24
17.0%
5.5%
Q3 24
-0.0%
-9.9%
Q2 24
-15.3%
-10.4%
Capex Intensity
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
6.0%
1.6%
Q3 25
12.5%
1.4%
Q2 25
16.5%
1.0%
Q1 25
16.5%
0.5%
Q4 24
12.0%
0.6%
Q3 24
17.7%
0.5%
Q2 24
21.1%
0.7%
Cash Conversion
ASPN
ASPN
EOLS
EOLS
Q1 26
Q4 25
98.67×
Q3 25
Q2 25
Q1 25
Q4 24
3.14×
Q3 24
Q2 24
0.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ASPN
ASPN

Energy Industrial$14.5M35%
Other$13.9M34%
Thermal Barrier$12.9M31%

EOLS
EOLS

Product revenue, net$72.7M99%
Service revenue$390.0K1%

Related Comparisons